{"id":"AGY-FED-HEALTH-OTHER-015","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"Drug Enforcement Administration, Diversion Control Division","authority":"21 U.S.C. 802(54)(D), 829; 21 C.F.R. 1306.04-.11","instrument":"DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree)","title":"How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency","dateIssued":"2020-03-31","effective":"2020-03-31","end":"For the duration of the public health emergency, unless DEA specifies an earlier date","startDate":"2020-03-31","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"addressees":["DEA-registered practitioners","pharmacies"],"clause":"In response to the COVID-19 public health emergency declared by the Secretary of Health and Human Services, the Drug Enforcement Administration (DEA) has adopted policies to allow DEA-registered practitioners to prescribe controlled substances without having to interact in-person with their patients. These policies are effective beginning March 31, 2020, and will remain in effect for the duration of the public health emergency, unless DEA specifies an earlier date.","enforcement":"Prescribing outside the stated policies unlawful under 21 U.S.C. 829 and 841-843","functions":["TM telehealth","CL clinical","RT pharmacy"],"notes":"DEA\u0027s own consolidated statement of the telemedicine, telephone, email and pharmacy-transmission methods permitted in the emergency.","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-023)(DEA075)Decision_Tree_(Final)_33120_2007.pdf","snapshot":"https://web.archive.org/web/20200409122711/https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-023)(DEA075)Decision_Tree_(Final)_33120_2007.pdf","fileExists":true,"fileBytes":143842,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-015","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-015","citation":"Drug Enforcement Administration, Diversion Control Division, DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree) (Mar. 31, 2020) (Ex. AGY-FED-HEALTH-OTHER-015)","stateName":"","related":["AGY-FED-HEALTH-OTHER-013"]}